振东制药 (300158)
Shanxi Zhendong Pharmaceutical Co.,Ltd
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 99230.31
- Circulating A-Shares(W): 99168.64
- Earnings Per Share(RMB): 0.0203
- Net Assets Per Share(RMB): 3.6486
- Operating Revenue(W RMB): 221450.71
- Total Profit(W RMB): 4574.13
- Net Profit Attributable to Parent(W RMB): 2036.41
- Net Profit Growth Rate(%): -49.25
- Weighted Return on Equity(%): 0.5600
- Operating Cash Flow Per Share(RMB): -0.6000
- Undistributed Profit Per Share(RMB): -1.3606
- Capital Reserve Per Share(RMB): 3.6622
2. Main Business
The main business covers:
- R&D, production, and sales of generic drugs and innovative drugs in oncology, dermatology, gastroenterology, urology, cardiovascular and cerebrovascular fields.
- A full industry chain of Chinese medicinal materials covering seed and seedling breeding, planting, processing, storage, and decoction pieces.
3. Company Basic Information
- Company Name: Shanxi Zhendong Pharmaceutical Co., Ltd.
- Listing Date: 2011-01-07
- Industry: Pharmaceutical Manufacturing
- Address: Zhendong Science and Technology Park, Guangming South Road, Shangdang District, Changzhi City, Shanxi Province
- Website: www.zdjt.com
- Company Profile: The company was established as a joint stock company on December 31, 2008, through the overall restructuring of Zhendong Co., Ltd. On December 10, 2008, the shareholders of Zhendong Co., Ltd. held a founding meeting and agreed to convert the net assets of RMB 240,766,222.22 as of September 30, 2008, audited by Lianda, into 100,000,000 shares of the joint stock company at a ratio of 41.534065%, with the remaining amount recorded as the company's capital reserve. The par value per share is RMB 1.00, and the registered capital is RMB 100,000,000. The promoters hold shares in the joint stock company in proportion to their equity in the limited company. On December 10, 2008, Lianda issued the "Capital Verification Report" (No. Lianda YZ [2008] B-1039), verifying that the registered capital at the time of the company's establishment had been fully paid by the promoters. On December 31, 2008, the company obtained the "Business License of Enterprise Legal Person" (Registration No.: 140421100000376) for the joint stock company issued by the Changzhi Administration for Industry and Commerce.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanxi Zhendong Health Industry Group Co., Ltd. | General Legal Person | 30223.02 | 30.08 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 3746.00 | 3.73 |
| 3 | Zhongtai Securities Asset Management - Supporting Private Enterprise Development Zhongtai Asset Management No. 1 FOF Collective Asset Management Plan - Securities Industry Supporting Private Enterprise Development Series Zhongtai Asset Management No. 45 Single Asset Management Plan | Asset Management Plan | 2702.82 | 2.69 |
| 4 | Qianhai Life Insurance Co., Ltd. - Own Funds | Insurance | 2169.99 | 2.16 |
| 5 | National Social Security Fund Portfolio 104 | Social Security Fund | 418.75 | 0.42 |
| 6 | Qianhai Life Insurance Co., Ltd. - Dividend Insurance Product | Insurance | 280.00 | 0.28 |
| 7 | Caitong Asset Management Healthcare Hybrid Securities Investment Fund Class A | Fund | 80.00 | 0.08 |
5. Concept Sectors
- Land Transfer
- Vitamins
- Rural Revitalization
- Generic Drugs
- Medical Aesthetics Concept
- Hepatitis Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Low-Profit Stocks
- Consecutive Losses
- Employee Stock Ownership
- Insurance New Entry
- Social Security Fund New Entry
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information